Alzheimer's Psychosis (Adept-4) Study
We are conducting a research study to test a new medication called KarXT for people with Alzheimer’s disease who are experiencing psychosis (hallucinations or delusions). The purpose of this study is to see how safe the medication is and whether it helps reduce symptoms of psychosis.
In this study, adults with mild to severe Alzheimer’s disease and moderate to severe psychosis will be randomly assigned to receive either KarXT or a placebo (a pill with no active medication). Neither participants nor the study team will know which one is being given during the study.
Study Eligibility
Age
Adults 50+
Gender
All genders welcome
Condition
Diagnosed with Alzheimer’s disease and experiencing hallucinations or delusions
Location
Daytona Beach, FL
Enrolling Now
Fill out the form below to see if you qualify for our Alzheimer’s Psychosis (Adept-4) study in Daytona Beach. Participation is completely voluntary, and all study-related care will be provided at no cost to you.
Why Join?
Study Sponsor
Discovering and delivering transformative medicines
Bristol Myers Squibb is a global biopharmaceutical company developing therapies across cardiovascular, oncology, immunology, and neuroscience. BMS is the sponsor of the KarXT (xanomeline-trospium) and BMS-986368 clinical programs in development at Arrow.
Participating in a clinical trial at Arrow Clinical Trials in Daytona Beach is an opportunity to take charge of your health while helping advance medical science — all while under the care of experienced local physicians.
From our blog
Hallucinations and delusions can appear in Alzheimer's disease. Learn what Alzheimer's psychosis is, how to respond as a caregiver, and research options in Daytona Beach.
Read the article →Daytona Neurology Clinical Trials
Psychosis includes symptoms like seeing or hearing things that aren’t there (hallucinations) or having false, often distressing beliefs (delusions). These symptoms can be very difficult for both patients and caregivers.
We currently conduct research studies in Hypertension, Orthopedics, Cardiology, and Neurology. Our trials include treatments for high blood pressure, joint pain, heart health, stroke recovery, migraines, and other conditions affecting the brain and nervous system.
While we cannot guarantee that participants will see improvements, they will receive study-related medical care at no cost and help researchers explore new treatment options that may benefit people with Alzheimer’s disease in the future.
No. All studies at Arrow Clinical Trials are provided at no cost to participants, and insurance is not required. Any procedures, tests, or study-related care will be covered by the trial sponsor.
Yes. Participants may receive compensation for their time and travel. The exact amount depends on the study and the number of visits required.
Each study has specific requirements, such as age range, medical history, and current health status. Our research team will review your information and conduct a screening process to determine if you qualify.
Your feedback is invaluable to us. Please take a moment to share your experience with Arrow Clinical Trials.
